Cartesian Therapeutics, Inc. (RNAC)
(Real Time Quote from BATS)
$16.22 USD
+0.06 (0.37%)
Updated Jul 22, 2024 01:32 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/15/2024
Time: -- |
6/2024 | $-0.81 | -19.26% |
Earnings Summary
For their last quarter, Cartesian Therapeutics, Inc. (RNAC) reported earnings of -$1.97 per share, missing the Zacks Consensus Estimate of -$0.81 per share. This reflects a negative earnings surprise of 143.21%. Look out for RNAC's next earnings release expected on August 15, 2024. For the next earning release, we expect the company to report earnings of -$0.86 per share, reflecting a year-over-year increase of 75.45%.
Earnings History
Price & Consensus
Zacks News for RNAC
Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates
RNAC: What are Zacks experts saying now?
Zacks Private Portfolio Services